doi: 10.1111/dom.14465 [DOI] [PMC free article] [PubMed] [Google Scholar] 237
Protecting your genetic privacy is critical for protecting your ability to purchase coverage in the future
doi:10.1017/neu.2013.35 Schmitz F, Scherer EB, Machado FR, et al
3638 Start with screening Because patients being considered for GLP-1 receptor agonist therapy are already at risk of developing acute pancreatitis due to having type 2 diabetes, obesity or both, screening for other potential risk factors before starting treatment is recommended
Track real body composition changes across quarters, not just weight on a scale
Zuckerman also said what matters more than the weight loss or food urges is how she feels: "My clothes are looser, I have more energy, I genuinely feel better." Cherie Marcus, 72, a retired fabric designer and theater editor based in Brooklyn, said she's also seen gradual progress even on the lowest 1.5-milligram dose of the drug